← All indications
Lactose Intolerance
The condition resulting from the absence or deficiency of LACTASE in the MUCOSA cells of the GASTROINTESTINAL TRACT, and the inability to break down LACTOSE in milk for ABSORPTION. Bacterial fermentation of the unabsorbed lactose leads to symptoms that range from a mild indigestion (DYSPEPSIA) to severe DIARRHEA. Lactose intolerance may be an inborn error or acquired.
Drugs by status
Approved for this indication (1)
Phase 3 trials (2)
Other trials (17)
- sucrose
- synthetic ppargamma ligand
- simethicone
- glucose
- acid lactase
- bifidobacteria adolescentis bd1
- bifidobacterium bifidum
- bifidobacterium longum
- lactobacillus plantarum
- aspergillus oryzae
- yogurt bacteria
- bacillus coagulans
- Streptococcus thermophilus
- sodium chloride
- Lactobacillus acidophilus
- Pediococcus acidilactici
- alverine
Organizations
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (6)
Organization Involved with Other Experimental Indications (14)
- Danisco
- Danone Research
- Vitacare Gmbh & Co. KG
- Huazhong University of Science and Technology
- Hospital Juarez de Mexico
- Institut National de la Santé Et de la Recherche Médicale, France
- McGill University
- University of Mary Hardin-Baylor
- Tel Aviv University
- University of Chile
- University of Lille
- French society of Gastroenterology
- Ambrosia - SupHerb Ltd.
- Manzo Pharmaceuticals